Novo Nordisk yakaburitsa yayo 2022 zvemari chirevo: Semaglutide yakatengeswa nemadhora zviuru gumi nemazana mapfumbamwe emadhora.

 NEWS    |      2023-07-31

Munguva pfupi yapfuura, Novo Nordisk yakaburitsa zviri pamutemo chirevo chayo che2022. Dhata inoratidza kuti Novo Nordisk's yakazara kutengesa muna 2022 ichasvika 176.954 bhiriyoni Danish krone (US $ 24.994 bhiriyoni, iyo shanduko yekuchinja yakaziviswa mumushumo wegore, zvakafanana pazasi), kusvika 26% gore pagore, purofiti inoshanda ichasvika 74.809 bhiriyoni Danish krone. (US $ 10.566 bhiriyoni), kumusoro 28% gore pagore, uye mambure purofiti ichave 55.525 bhiriyoni Danish krone (US $ 7.843 bhiriyoni), kumusoro 16% gore pagore. Kuita kwacho kunoshamisa zvikuru.

Kushanda kwakanaka kwaNovo Nordisk kunobva kupi? Mhinduro ndeye GLP-1 analogue. MuNovo Nordisk's pombi yechigadzirwa, zvigadzirwa zvinogona kukamurwa kuita mhando ina: GLP-1 analogues, insulin uye analogues, coagulation zvinhu uye mamwe metabolic mahormone, nekutengesa kwe83.371 bhiriyoni Danish krone ($ 11.176 bhiriyoni, kusasanganisa uremu tsono), 52.952 bhiriyoni Danish krone ($ 7.479 bhiriyoni), 11.706 bhiriyoni Danish krone ($ 1.653 bhiriyoni) uye 7.138 bhiriyoni Danish krone ($ 1.008 bhiriyoni), zvichiteerana. Pakati peGLP-1 analogues, kutengesa kweLiraglutide hypoglycemic jekiseni kwave kuderera gore negore, uku.Semaglutideinobata maziso zvakanyanya, nekutengesa kwakazara kwe10.882 bhiriyoni emadhora muna 2022.

Novo Nordisk released its 2022 financial report: Semaglutide sold for $10.9 billion